Volastra Therapeutics, Inc.
Pharmaceutical company · New York, United States
Volastra Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2025.
Volastra Therapeutics at a glance
What does Volastra Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $30.1 million sold (2025).
Frequently asked questions about Volastra Therapeutics
Where is Volastra Therapeutics headquartered?
Volastra Therapeutics, Inc. is headquartered in New York, United States.
What does Volastra Therapeutics do?
Volastra Therapeutics, Inc. is a pharmaceutical company.
When was Volastra Therapeutics founded?
The earliest incorporation on record for Volastra Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences